The Inherited Genetic Component of Sporadic Pancreatic Adenocarcinoma

Pancreatic cancer, like many other complex diseases, has genetic and environmental components to its etiology. It is likely that relatively common genetic variants with modest effects on pancreatic cancer risk play an important role in both familial and sporadic forms of the disease, either individually or in interaction with environmental factors. The relatively high frequency of such variants means that they could potentially explain a substantial portion of disease risk. Here we summarize the findings published to date from genetic association studies1. In general, very few low-penetrance variants have been identified and those that have require replication in independent studies. Possible gene-environment interactions arising from these studies also require replication. More comprehensive approaches are needed to make progress, including global analyses of biologically sound pathways and genome-wide association studies. Large sample sizes are required to do this appropriately and multi-study consortia make this possible. A number of consortia of pre-existing studies have already been formed, and these will facilitate the identification of further low-penetrance variants and gene-environment interaction. However, these approaches do not substitute for the design of novel, sufficiently powered studies that apply uniform criteria to case selection, the acquisition of environmental exposure information, and to biological sample collection.

[1]  Ying Wang,et al.  Genomewide association study of leprosy. , 2009, The New England journal of medicine.

[2]  M. McCarthy,et al.  Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.

[3]  Dieter Niederacher,et al.  Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.

[4]  L. Tamer,et al.  The association between N‐acetyltransferase 2 gene polymorphisms and pancreatic cancer , 2008, Cell biochemistry and function.

[5]  D. Christiani,et al.  Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma , 2008, Cancer.

[6]  Manal M. Hassan,et al.  XRCC2 and XRCC3 Gene Polymorphismand Risk of Pancreatic Cancer , 2008, The American Journal of Gastroenterology.

[7]  P. Ruszniewski,et al.  Risk of Pancreatic Adenocarcinoma in Patients With Hereditary Pancreatitis: A National Exhaustive Series , 2008, The American Journal of Gastroenterology.

[8]  S. Chari,et al.  Is autoimmune pancreatitis a risk factor for pancreatic cancer? , 2007, Pancreas.

[9]  Franco Mosca,et al.  Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma , 2007, Pancreatology.

[10]  Xavier Estivill,et al.  Copy Number Variants and Common Disorders: Filling the Gaps and Exploring Complexity in Genome-Wide Association Studies , 2007, PLoS genetics.

[11]  Eithne Costello,et al.  Biology and management of pancreatic cancer , 2007, Postgraduate Medical Journal.

[12]  W. Bamlet,et al.  Mitochondrial Genetic Polymorphisms and Pancreatic Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.

[13]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[14]  H. Friess,et al.  HFE genotypes in patients with chronic pancreatitis and pancreatic adenocarcinoma , 2007, Genetics in Medicine.

[15]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[16]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[17]  Douglas B. Evans,et al.  Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians , 2007, Clinical Cancer Research.

[18]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[19]  Manal M. Hassan,et al.  Effects of base excision repair gene polymorphisms on pancreatic cancer survival , 2007, International journal of cancer.

[20]  K. Christensen,et al.  What genome-wide association studies can do for medicine. , 2007, The New England journal of medicine.

[21]  Manal M. Hassan,et al.  Glutathione S‐transferase gene polymorphisms and risk and survival of pancreatic cancer , 2007, Cancer.

[22]  V. Beral,et al.  Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis , 2007, British Journal of Cancer.

[23]  Manal M. Hassan,et al.  The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. , 2007, Cancer letters.

[24]  A. Zauber,et al.  Allergies, variants in IL-4 and IL-4Rα genes, and risk of pancreatic cancer , 2007 .

[25]  J. Izbicki,et al.  Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis. , 2007, Anticancer research.

[26]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[27]  A. Andriulli,et al.  Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. , 2006, World journal of gastroenterology.

[28]  F. Real,et al.  Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer , 2006, Journal of Molecular Medicine.

[29]  S. Larsson,et al.  Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. , 2006, Gastroenterology.

[30]  X. Miao,et al.  [Polymorphisms of the DNA repair genes XRCC1 and XPC: relationship to pancreatic cancer risk]. , 2006, Wei sheng yan jiu = Journal of hygiene research.

[31]  K. Hess,et al.  Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  E. Holly,et al.  Inflammation, Genetic Polymorphisms in Proinflammatory Genes TNF-A, RANTES, and CCR5, and Risk of Pancreatic Adenocarcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[33]  Manal M. Hassan,et al.  Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. , 2006, Cancer research.

[34]  Manal M. Hassan,et al.  Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. , 2006, Cancer detection and prevention.

[35]  Manal M. Hassan,et al.  Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. , 2006, Carcinogenesis.

[36]  W. Greenhalf,et al.  RNASEL germline variants are associated with pancreatic cancer , 2005, International journal of cancer.

[37]  M. de Andrade,et al.  Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma , 2005, Gut.

[38]  H. Friess,et al.  Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases , 2005, Journal of Medical Genetics.

[39]  N. Malats,et al.  NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.

[40]  W. Tan,et al.  Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  C. Iacobuzio-Donahue,et al.  Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. , 2005, Clinical Gastroenterology and Hepatology.

[42]  M. de Andrade,et al.  Risk of malignancy in first‐degree relatives of patients with pancreatic carcinoma , 2005, Cancer.

[43]  Manal M. Hassan,et al.  5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[44]  Ireland,et al.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. , 2005 .

[45]  S Pancreatic,et al.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas , 2005, Gut.

[46]  H. Nevanlinna,et al.  Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: A report from Finland , 2005, Scandinavian journal of gastroenterology.

[47]  F. Couch,et al.  Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. , 2005, Cancer research.

[48]  K. Fearon,et al.  Interferon-γ polymorphisms correlate with duration of survival in pancreatic cancer , 2004 .

[49]  J. Peto,et al.  The search for low-penetrance cancer susceptibility alleles , 2004, Oncogene.

[50]  W. Greenhalf,et al.  Clinical and genetic characteristics of hereditary pancreatitis in Europe. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  Lon R. Cardon,et al.  The complex interplay among factors that influence allelic association , 2004, Nature Reviews Genetics.

[52]  R. Bell,et al.  International variation in pancreatic cancer mortality for the period 1955–1998 , 2002, European Journal of Epidemiology.

[53]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[54]  R. Hruban,et al.  Polymorphisms of SPINK1 N34S and CFTR in Patients with Sporadic and Familial Pancreatic Cancer , 2003, Cancer biology & therapy.

[55]  M. Manns,et al.  UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. , 2003, Gastroenterology.

[56]  A. Nouvenne,et al.  Association of keratin 8 gene mutation with chronic pancreatitis. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[57]  R. Hruban,et al.  Fanconi anemia gene mutations in young-onset pancreatic cancer. , 2003, Cancer research.

[58]  H. Witt,et al.  N34S, a Pancreatitis Associated SPINK1 Mutation, Is Not Associated with Sporadic Pancreatic Cancer , 2003, Pancreatology.

[59]  D. Botstein,et al.  Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.

[60]  A. Ziegler,et al.  BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.

[61]  Douglas F Easton,et al.  Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.

[62]  E. Holly,et al.  A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. , 2002, Cancer research.

[63]  T. Beaty,et al.  Evidence for a major gene influencing risk of pancreatic cancer , 2002, Genetic epidemiology.

[64]  Leonid Kruglyak,et al.  A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. , 2002, American journal of human genetics.

[65]  E. Holly,et al.  A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. , 2002, Journal of the National Cancer Institute.

[66]  S. Kern,et al.  Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families , 2002, Cancer.

[67]  N. Lemoine,et al.  Pancreatic Cancer Genetics , 2001, Pancreatology.

[68]  R. Brand,et al.  Hereditary Pancreatic Cancer , 2001, Pancreatology.

[69]  N. Malats Gene-Environment Interactions in Pancreatic Cancer , 2001, Pancreatology.

[70]  W. Greenhalf,et al.  Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients , 2001, Pancreatology.

[71]  H. Blum,et al.  Mutations of the cystic fibrosis gene in patients with chronic pancreatitis , 2001, American Journal of Gastroenterology.

[72]  J. Cameron,et al.  Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[73]  X. Estivill,et al.  Cystic fibrosis transmembrane regulator ( CFTR ) (cid:196) F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer , 2000 .

[74]  X. Estivill,et al.  Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. , 2001, Gut.

[75]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[76]  K. Fearon,et al.  A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer , 2000, British Journal of Cancer.

[77]  N. Gruis,et al.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) , 2000, International journal of cancer.

[78]  N. Risch Searching for genetic determinants in the new millennium , 2000, Nature.

[79]  W. Foulkes,et al.  Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma , 2000, British Journal of Cancer.

[80]  N. Malats,et al.  Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer. , 1998, Journal of clinical epidemiology.

[81]  P. Boyle,et al.  Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[82]  J. Fraumeni,et al.  Multiple primary cancers in families with Li-Fraumeni syndrome. , 1998, Journal of the National Cancer Institute.

[83]  H. Lee,et al.  Association Between Genetic Polymorphisms of the Cytochromes P-450 (1A1, 2D6, and 2E1) and the Susceptibility to Pancreatic Cancer , 1997, The Korean journal of internal medicine.

[84]  T. Smyrk,et al.  An update of HNPCC (Lynch syndrome). , 1997, Cancer genetics and cytogenetics.

[85]  C. Moskaluk,et al.  Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.

[86]  C. la Vecchia,et al.  Family history and the risk of liver, gallbladder, and pancreatic cancer. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[87]  A. Swerdlow,et al.  A cohort study of cystic fibrosis and malignancy. , 1993, British Journal of Cancer.

[88]  F. Giardiello,et al.  Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. , 1993, Gut.

[89]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer , 1993 .

[90]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. , 1993, The New England journal of medicine.

[91]  P. Boyle,et al.  Reported family aggregation of pancreatic cancer within a population-based case-control study in the francophone community in Montreal, Canada , 1991, International journal of pancreatology : official journal of the International Association of Pancreatology.

[92]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[93]  B. Terracini Evaluation of Carcinogenic Risk of Chemicals to Man , 1972 .

[94]  F. Mícek [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.